Table 2.
Medication Use
| Medication | Total (n = 20,663) | Medical therapy patients (n = 8,630) | Revascularized patients (n = 12,033) | p value |
|---|---|---|---|---|
| Medications within 3 months pre-index, % | ||||
| ACE or ARB | 68.0 | 71.1 | 65.8 | < 0.001 |
| Thienopyridines (clopidogrel) | 16.8 | 17.1 | 16.6 | 0.34 |
| β blockers | 63.2 | 63.5 | 63.0 | 0.46 |
| Calcium channel blockers | 38.4 | 38.5 | 38.3 | 0.81 |
| Nitrates | 48.1 | 41.0 | 53.3 | < 0.001 |
| Statins | 75.3 | 76.7 | 74.2 | < 0.001 |
| Medications within 3 months post-index, % | ||||
| ACE or ARB | 71.0 | 72.9 | 69.7 | < 0.001 |
| Thienopyridines (clopidogrel) | 47.6 | 20.2 | 67.3 | < 0.001 |
| β blockers | 69.4 | 67.1 | 71.0 | < 0.001 |
| Calcium channel blockers | 38.3 | 41.2 | 36.3 | < 0.001 |
| Nitrates | 31.9 | 34.8 | 29.9 | < 0.001 |
| Statins | 84.7 | 82.1 | 86.7 | < 0.001 |
| Medications within 12 months post-index, % | ||||
| ACE or ARB | 81.1 | 82.0 | 80.4 | 0.004 |
| Thienopyridines (clopidogrel) | 52.3 | 27.2 | 70.3 | < 0.001 |
| β blockers | 77.6 | 76.7 | 78.2 | 0.010 |
| Calcium channel blockers | 45.5 | 48.1 | 43.7 | < 0.001 |
| Nitrates | 43.6 | 47.1 | 41.2 | < 0.001 |
| Statins | 93.4 | 91.5 | 94.7 | < 0.001 |
ACE angiotension converting enzyme inhibitors; ARB angiotension receptor blockers